Literature DB >> 9192727

Isolation and molecular cloning of epidermal- and hair follicle-specific peptidylarginine deiminase (type III) from rat.

T Nishijyo1, A Kawada, T Kanno, M Shiraiwa, H Takahara.   

Abstract

Peptidylarginine deiminase (PAD) is a post-translational modification enzyme that catalyzes deimination of arginine residues of proteins in the presence of calcium ions. There are three types of PAD in rodent tissues: PAD types I, II, and III [Terakawa et al. (1991) J. Biochem. 110, 661-666]. Type III enzyme was detected only in the epidermis and in hair follicles. In this study, we have purified PAD type III from 2-day-old rat epidermis by a four-step procedure that included soybean trypsin inhibitor-affinity chromatography. The enzyme was purified about 600-fold from the crude extract and the recovery was 23%. The final preparation of the enzyme gave only a single protein band on SDS-PAGE and showed an apparent molecular weight of 76,000. Subsequently, we cloned and sequenced the full-length cDNA encoding rat PAD type III by reverse transcription-polymerase chain reaction (RT-PCR) using degenerate oligonucleotide primers designed from the internal amino acid sequences and by the rapid amplification of the cDNA ends method. The composite cDNA sequence contained a 5' untranslated region of 42 bp, an open reading frame of 1,995 bases that encoded 664 amino acids (Mr=75,036), a 3' untranslated region of 1,063 bp, and part of a poly(A)+ tail. The entire reading frame sequence of rat PAD type III showed 51% homology with that of rat PAD type II, and the C-terminal region is highly conserved between the two types. The cloned gene was expressed in Escherichia coli cells to produce PAD type III, which had not only enzymatic activity, but also immunoreactivity against specific antibodies toward PAD type II. Furthermore, the specific expression of the enzyme in the epidermis and hair follicles was confirmed by RT-PCR assays of mRNAs from several tissues.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9192727     DOI: 10.1093/oxfordjournals.jbchem.a021667

Source DB:  PubMed          Journal:  J Biochem        ISSN: 0021-924X            Impact factor:   3.387


  5 in total

1.  cDNA cloning, gene organization and expression analysis of human peptidylarginine deiminase type I.

Authors:  Marina Guerrin; Akihito Ishigami; Marie-Claire Méchin; Rachida Nachat; Séverine Valmary; Mireille Sebbag; Michel Simon; Tatsuo Senshu; Guy Serre
Journal:  Biochem J       Date:  2003-02-15       Impact factor: 3.857

2.  A family based study shows no association between rheumatoid arthritis and the PADI4 gene in a white French population.

Authors:  L Caponi; E Petit-Teixeira; M Sebbag; F Bongiorni; S Moscato; F Pratesi; C Pierlot; J Osorio; S Chapuy-Regaud; M Guerrin; F Cornelis; G Serre; P Migliorini
Journal:  Ann Rheum Dis       Date:  2004-10-14       Impact factor: 19.103

3.  Peptidylarginine deiminase 2 (PAD2) overexpression in transgenic mice leads to myelin loss in the central nervous system.

Authors:  Abdiwahab A Musse; Zhen Li; Cameron A Ackerley; Dorothee Bienzle; Helena Lei; Roberto Poma; George Harauz; Mario A Moscarello; Fabrizio G Mastronardi
Journal:  Dis Model Mech       Date:  2008-11-06       Impact factor: 5.758

4.  Inhibition of peptidyl-arginine deiminases reverses protein-hypercitrullination and disease in mouse models of multiple sclerosis.

Authors:  Mario A Moscarello; Helena Lei; Fabrizio G Mastronardi; Shawn Winer; Hubert Tsui; Zhen Li; Cameron Ackerley; Li Zhang; Reinout Raijmakers; D Denise Wood
Journal:  Dis Model Mech       Date:  2012-11-01       Impact factor: 5.758

5.  Microglial expression of peptidylarginine deiminase 2 in the prenatal rat brain.

Authors:  Hiroaki Asaga; Akihito Ishigami
Journal:  Cell Mol Biol Lett       Date:  2007-06-20       Impact factor: 5.787

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.